MA
$22.49
+0.32
(+1.44%)
As of May 26, 2026, 8:48 PM EDT
Macerich REIT (MAC) is trading up at $22.49 (+1.44%), as of the latest quote. It is a Russell 2000 constituent in the Real Estate sector.
Recent News (20)
-
Rocket Pharmaceuticals CEO Shah sells $171,840 in stock Rocket Pharmaceuticals CEO Shah sells $171,840 in stock
-
KalVista Pharmaceuticals CDO sells shares worth $63,157 KalVista Pharmaceuticals CDO sells shares worth $63,157
-
KalVista Pharmaceuticals CMO Audhya Sells $71,916 in Stock KalVista Pharmaceuticals CMO Audhya Sells $71,916 in Stock
-
Exiled leader vows to return to Venezuela, run for president Venezuelan opposition leader María Corina Machado on Saturday said she plans to return to Venezuela before the end of 2026 and run for president again. Speaking at a gathering of fellow Venezuelan opp…
-
Intuitive Machines stock tumbles after NASA rover contract news
Intuitive Machines stock tumbles after NASA rover contract news
-
Down Over 10% This Year: 1 Free-Cash-Flow Machine Under $30 to Buy and Hold Forever Down Over 10% This Year: 1 Free-Cash-Flow Machine Under $30 to Buy and Hold Forever
-
The one thing successful companies are doing with AI Companies will not win by turning AI into a fear test. They will win by creating workplaces where human judgment gets more valuable as machine output gets cheaper.
-
Humacyte presents dialysis access vessel research at VASA meeting
Humacyte presents dialysis access vessel research at VASA meeting
-
RenovoRx reports pharmacokinetic data from pancreatic trial
RenovoRx reports pharmacokinetic data from pancreatic trial
-
Canaccord Cuts PT on Regeneron Pharmaceuticals (REGN), Cites a Disappointing Event Canaccord Cuts PT on Regeneron Pharmaceuticals (REGN), Cites a Disappointing Event
-
Bernstein Lifts PT on Arrowhead Pharmaceuticals (ARWR) Following Biotech’s Solid Start to 2026 Bernstein Lifts PT on Arrowhead Pharmaceuticals (ARWR) Following Biotech’s Solid Start to 2026
-
Here’s the defensive stock-market trade that works no matter where bond yields end up JPMorgan says low-volatility stocks have underperformed this year, are ready to bust out no matter what the macro backdrop looks like.
-
Form 6K TAKEDA PHARMACEUTICAL CO LTD For: 26 May
Form 6K TAKEDA PHARMACEUTICAL CO LTD For: 26 May
-
Hyperliquid takes a swing at Polymarket with macro outcome bets The decentralized exchange’s new HIP-4 product lets traders bet on offchain events like inflation and interest-rate decisions, using validators rather than UMA-style external dispute resolution.
-
Bitcoin stalls near $76,500 as muted trading points to macro wait-and-see Enflux says “the bid is there” but no one is adding size, while Glassnode data shows easing selling pressure alongside weaker market activity.
-
Jim Cramer Reveals Why International Business Machines (IBM) Should Be Doing Better Jim Cramer Reveals Why International Business Machines (IBM) Should Be Doing Better
-
-
Top 5 Taiwan Electronics Stocks to Watch, According to Macquarie
Top 5 Taiwan Electronics Stocks to Watch, According to Macquarie
-
Debt Spirals vs. AI Factories: The Great Macro Divide of 2026 Debt Spirals vs. AI Factories: The Great Macro Divide of 2026
-
6 kitchen gadgets that make adulting feel easier From a robot stirring your soup to a bread machine that kneads your dough, here are 6 gadgets that may make you feel like you’ve won adulthood.